课题基金 / 基金详情

PHARMACOKINETIC STUDY OF TAXOL & CARBOPLATIN WITH FILGRASTIM IN LUNG CARCINOMA

PHARMACOKINETIC STUDY OF TAXOL & CARBOPLATIN WITH FILGRASTIM IN LUNG CARCINOMA
紫杉醇的药代动力学研究
批准号：
6245696
负责人：
CHANDRA BELANI
金额：
$1.76万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-03-18 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6245696
关键词：
carboplatin clinical research clinical trial phase I colony stimulating factor human subject human therapy evaluation neoplasm /cancer chemotherapy nonsmall cell lung cancer paclitaxel pharmacokinetics

项目摘要

项目成果

CHANDRA BELANI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this phase I/II study is to determine the maximum tolerated dose of taxol in combination with carboplatin in previously untreated patients with advanced or recurrent non-small cell lung cancer (NSCLC); define the pharmacokinetics of carboplatin with combination therapy and correlate 24 hour total plasma platinum concentration and pharmacodynamic consequences of therapy with carboplatin area under the concentration curve.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: A PHASE I STUDY IN ADVANCED SOLID MALIGNANCIES (NCI 7967)
CLINICAL TRIAL: PI & PHARMACOKINETIC STUDY OF DRUG FOR SOLID TUMORS & LYMPHOMAS
CLINICAL TRIAL: PI &PHARMACOKINETIC SINGLE AGENT STUDY OF DRUG IN PTS W ADV MALI
Phase I Clinical Trials of Novel Anticancer Agents
海外基金